Boy Dies From Cardiac Arrest After Participating in Gene Therapy Study

Pfizer Logo | Image by Pfizer/Facebook
Pfizer Logo | Image by Pfizer/Facebook

Gateway Pundit reports that, “a young boy has died due to cardiac arrest after receiving the company’s experimental gene therapy for Duchenne muscular dystrophy.

“A Pfizer spokesperson told Reuters in an exclusive email, “A fatal serious adverse event was reported as cardiac arrest for a participant in the Phase 2 DAYLIGHT study.

“Pfizer’s gene therapy trial is currently testing children two to three-year-olds who have Duchenne muscular dystrophy.”

To read the whole Gateway Pundit story, click HERE.

Support our non-profit journalism

Submit a Comment

Your email address will not be published. Required fields are marked *

Continue reading on the app
Expand article